Cargando...

Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria

Congenital erythropoietic porphyria (CEP), also known as Günther’s disease, results from a deficient activity in the fourth enzyme, uroporphyrinogen III synthase (UROIIIS), of the heme pathway. Ciclopirox (CPX) is an off-label drug, topically prescribed as an antifungal. It has been recently shown t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pers Med
Autores principales: Bernardo-Seisdedos, Ganeko, Charco, Jorge M., SanJuan, Itxaso, García-Martínez, Sandra, Urquiza, Pedro, Eraña, Hasier, Castilla, Joaquín, Millet, Oscar
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230281/
https://ncbi.nlm.nih.gov/pubmed/34071291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060485
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!